| Product Code: ETC7548816 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neurology Clinical Trials Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neurology Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 India Neurology Clinical Trials Market - Industry Life Cycle |
3.4 India Neurology Clinical Trials Market - Porter's Five Forces |
3.5 India Neurology Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 India Neurology Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F |
3.7 India Neurology Clinical Trials Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Neurology Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in India |
4.2.2 Growing investments in healthcare infrastructure and research development |
4.2.3 Rising demand for innovative treatments and therapies in neurology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for conducting clinical trials in India |
4.3.2 Limited availability of skilled professionals in the field of neurology |
4.3.3 High costs associated with conducting clinical trials and research in neurology |
5 India Neurology Clinical Trials Market Trends |
6 India Neurology Clinical Trials Market, By Types |
6.1 India Neurology Clinical Trials Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 India Neurology Clinical Trials Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 India Neurology Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.4 India Neurology Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.5 India Neurology Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.6 India Neurology Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 India Neurology Clinical Trials Market, By Study Design |
6.2.1 Overview and Analysis |
6.2.2 India Neurology Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F |
6.2.3 India Neurology Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F |
6.2.4 India Neurology Clinical Trials Market Revenues & Volume, By Expanded Access, 2021- 2031F |
6.3 India Neurology Clinical Trials Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 India Neurology Clinical Trials Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.3.3 India Neurology Clinical Trials Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 India Neurology Clinical Trials Market Revenues & Volume, By Alzheimer's Disease (AD), 2021- 2031F |
6.3.5 India Neurology Clinical Trials Market Revenues & Volume, By Parkinson's Disease (PD), 2021- 2031F |
6.3.6 India Neurology Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
7 India Neurology Clinical Trials Market Import-Export Trade Statistics |
7.1 India Neurology Clinical Trials Market Export to Major Countries |
7.2 India Neurology Clinical Trials Market Imports from Major Countries |
8 India Neurology Clinical Trials Market Key Performance Indicators |
8.1 Patient recruitment rate for neurology clinical trials |
8.2 Success rate of neurology clinical trials in India |
8.3 Adoption rate of new technologies and treatments in neurology clinical trials in India |
9 India Neurology Clinical Trials Market - Opportunity Assessment |
9.1 India Neurology Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 India Neurology Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F |
9.3 India Neurology Clinical Trials Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Neurology Clinical Trials Market - Competitive Landscape |
10.1 India Neurology Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 India Neurology Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here